Dechra Pharmaceuticals PLC Exercise of LTIP options (4797Q)
30 November 2016 - 5:10AM
UK Regulatory
TIDMDPH
RNS Number : 4797Q
Dechra Pharmaceuticals PLC
29 November 2016
29 November 2016
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by persons
discharging managerial responsibilities (PDMR) and persons closely
associated with them (PCA)
Exercise of LTIP options:
Dechra Pharmaceuticals PLC announces that on 28 November 2016,
the following PDMRs exercised nil cost options over ordinary shares
of 1p each in the Company. The options were granted to them on 27
November 2013 pursuant to the Dechra Pharmaceuticals PLC Long Term
Incentive Plan (the LTIP). The exercise of the options was subject
to the achievement of performance conditions which vested at 96.25%
of the total award. The PDMRs named below received in satisfaction
of the vesting of their awards under the LTIP the number of
ordinary shares set out below:
Name Capacity Options Exercised Total beneficial Percentage
shareholding of issued
following share
this announcement capital
Ian Page Director 124,375 876,541 0.942%
Tony
Griffin Director 32,849 84,953 0.091%
The Notification of Dealing Forms set out below are provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- ----------------------------------------------------------------
a) Name Ian Page
--- ----------------------------- ---------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a) Position/status Director
--- ----------------------------- ---------------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- ---------------------------------
3. Details of the Issuer
--- ----------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- ---------------------------------
b) LEI code N/A
--- ----------------------------- ---------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
Identification ISIN: GB0009633180
code
--- ----------------------------- ---------------------------------
b) Nature of Exercise of nil cost options
the transaction under the Company's Long Term
Incentive Plan
--- ----------------------------- ---------------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
Nil cost 124,375
--- ----------------------------- ---------------- ---------------
d) Aggregated
information
* Aggregate volume N/A
* Price
--- ----------------------------- ---------------------------------
e) Date of the 2016.11.28
transaction
--- ----------------------------- ---------------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- ---------------------------------
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- ----------------------------------------------------------------
a) Name Tony Griffin
--- ----------------------------- ---------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a) Position/status Director
--- ----------------------------- ---------------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- ---------------------------------
3. Details of the Issuer
--- ----------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- ---------------------------------
b) LEI code N/A
--- ----------------------------- ---------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
Identification ISIN: GB009633180
code
--- ----------------------------- ---------------------------------
b) Nature of Exercise of nil cost options
the transaction under the Company's Long Term
Incentive Plan
--- ----------------------------- ---------------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
Nil cost 32,849
--- ----------------------------- ---------------- ---------------
d) Aggregated
information
* Aggregate volume N/A
* Price
--- ----------------------------- ---------------------------------
e) Date of the 2016.11.28
transaction
--- ----------------------------- ---------------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- ---------------------------------
For further information, please contact:
Suzana Cross, General Counsel and Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBLBPTMBMTBLF
(END) Dow Jones Newswires
November 29, 2016 13:10 ET (18:10 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024